To determine whether SRC-2 cooperates with FXR in activating SHP expression in human liver cancer cells, we performed transactivation assays with a luciferase reporter construct harboring the proximal promoter of SHP, and a truncated reporter construct harboring a deletion that encompasses the FXR binding site. This evidence concerns the gene NR1H4 and liver cancer.